RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation

Sigal Gery1, Dorothy J Park, Peter T Vuong

  • 1Division of Hematology/Oncology, UCLA School of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. gerys@cshs.org

Abstract

Insights

Retinoic acid (RA) induces the stress gene RTP801 in myeloid cells, impacting differentiation and growth. This RA-regulated gene may offer a new therapeutic target for leukemia.

Area of Science:

  • Molecular biology
  • Cellular differentiation
  • Cancer research

Background:

  • Retinoids, including retinoic acid (RA), are vital for regulating cellular processes like myeloid progenitor differentiation.
  • Understanding RA target genes is crucial for comprehending normal and malignant myeloid cell development.

Purpose of the Study:

  • To identify and characterize novel retinoic acid (RA) target genes in myeloid cells.
  • To investigate the role of RTP801 as an RA target gene in acute myeloid leukemia (AML) and normal hematopoiesis.

Main Methods:

  • Gene expression analysis of RTP801 in AML cell lines and normal CD34(+) cells treated with RA.
  • Investigating the role of C/EBPepsilon in regulating RTP801 expression.
  • Functional studies using RTP801 overexpression and shRNA-mediated silencing in U937 cells.
  • Assessment of mTOR pathway activity under varying RTP801 and hypoxia conditions.

Main Results:

  • RTP801 was identified as a novel, early retinoic acid (RA) target gene in myeloid cells.
  • RTP801 mRNA levels increased during RA-induced differentiation of AML cells and normal CD34(+) cells.
  • Overexpression of RTP801 inhibited U937 cell growth and induced apoptosis, while silencing RTP801 impaired RA-induced differentiation.
  • RTP801 regulates the mTOR pathway, affecting hypoxia-induced inhibition.

Conclusions:

  • RTP801 is a significant RA-regulated gene involved in myeloid differentiation.
  • RTP801 plays a critical role in both normal and malignant myeloid cell maturation.
  • RTP801 represents a potential therapeutic target for leukemia treatment.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...